NFKB1 and cancer: These inflammatory mediators further activate multiple pivotal signaling pathways including Janus kinase/signal transducers and activators of transcription (JAK/STAT) and nuclear factor kappa B (NF-κB), which restricts the efficacy of chemotherapy by promoting cancer development and suppressing anti-tumor immunity (Liu and Cao 2016).